USA Scientists Awarded Research Grant

The National Institutes of Health has awarded a two-year, $423,500 grant to University of South Alabama (USA) scientists to conduct research on the amyloid precursor protein (APP) and its role in activating neutrophils to protect against bacterial infections. The principal investigators are Dr. Jonathon P. Audia, a professor of microbiology and immunology, and Dr. Robert A. Barrington, an associate professor of microbiology and immunology. The APP is best known for producing amyloid-beta, a key pathogenic molecule implicated in the development of Alzheimer’s disease and related dementias. However, there have been relatively few studies on the normal biological functions of APP, noted Audia. This research may also cast light on mechanisms underlying the long-term health problems faced by patients’ recovery after intensive care unit stays. Audia and Barrington said they previously made the exciting discovery that APP plays an important role in directing neutrophils during bacterial pneumonia.

Read More

Wellhouse Real Estate Adds Two Agents In Orange Beach

Wellhouse Real Estate Adds Two Agents In Orange Beach

Baldwin County Forensics Foundation Fundraiser Announced

Baldwin County Forensics Foundation Fundraiser Announced

MBA Executive Committee To Slate 2027 Positions

MBA Executive Committee To Slate 2027 Positions

Mobile, Baldwin County Bar Associations Hosting Joint Social

Mobile, Baldwin County Bar Associations Hosting Joint Social

Warren Averett Technology Group Named A Top MSP

Warren Averett Technology Group Named A Top MSP

USA Health Surgeon Performs First-In-Area Procedure Robotically

USA Health Surgeon Performs First-In-Area Procedure Robotically

USA Health Adds Urologist Specializing In Men’s Health

USA Health Adds Urologist Specializing In Men’s Health

Foley Library Opens

Foley Library Opens

Foley Airport Updates

Foley Airport Updates

Subscribe to our weekly newsletter

Sign up here for free to get Bay Business News email newsletter every Friday.

By subscribing, you agree to our User Agreement and Privacy Policy & Cookie Statement.

Something went wrong. Please check your entries and try again.